Results of a phase Ib study of SB-121, an investigational probiotic formulation, in participants with autism spectrum disorder https://www.medrxiv.org/content/10.1101/2022.11.14.22281882
Results of a phase Ib study of SB-121, an investigational probiotic formulation, in participants with autism spectrum disorder https://www.medrxiv.org/content/10.1101/2022.11.14.22281882